Advancing Cell & Gene Therapy in East Asia

Advancing Cell & Gene Therapy in East Asia is organized by IMAPAC Pte Ltd and will be held from Jun 14 - 15, 2023 at Songdo Convensia, Incheon, Seoul, South Korea.

Description:
The East Asia region is making great progress in developing cell and gene therapy to address and bring hope to the high unmet medical needs. As part of the new wave of advanced therapy medicinal product (ATMP), cell and gene therapy biopharmas in the East Asia region has contributed extensive capital investment in research & development of novel therapeutic agents, setting state-of-art manufacturing plants while collaborations are formed between multinational companies to accelerate the progress and developments of cell and gene therapy industry. Growing at a compound growth rate of above 14%, the cell and gene therapy market in East Asia is expected to reach USD 2.9 billion by 2028. Among the countries, China, Korea, Japan and Taiwan showed exceptional achievements in R&D of cell & gene therapy products and offered great potential for treatment of various diseases.

Additional details will be posted as soon as information is available.